3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Tuberous Sclerosis
4
Seizures
3
Lennox Gastaut Syndrome
3
Epilepsies, Myoclonic
3
Anxiety Disorders
2
Tuberous Sclerosis 2
1
Tuberous Sclerosis 1
1
Spasms, Infantile
1
Prostatic Neoplasms
1
Parasomnias
1
Pain
1
Neoplasms
1
Nausea
1
Marijuana Abuse
1
Liver Cirrhosis
1
Glioblastoma
1
Epilepsy
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Chemotherapy-Induced Peripheral Neuropathy
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Pain
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Behavior
1
Interventions
Capecitabine
42
Oxaliplatin
39
Fluorouracil
29
Leucovorin
23
Radiotherapy
22
Cetuximab
15
Bevacizumab
15
Irinotecan
13
Nivolumab
12
Magnetic Resonance Spectroscopy
11
Specimen Handling
9
Drug Therapy
9
Surgical Procedures, Operative
8
Folfox protocol
8
pembrolizumab
7
Radiotherapy, Intensity-Modulated
7
Chemoradiotherapy
7
Biopsy
7
trifluridine tipiracil drug combination
6
Radiation
6
tislelizumab
5
sintilimab
5
regorafenib
5
dehydroftorafur
5
X-Rays
5
Surveys and Questionnaires
5
Sigmoidoscopy
5
Endoscopy
5
Consolidation Chemotherapy
5
spartalizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Cannabidiol
×
1 year
×
Clear all
No trials found.